Teplizumab
Drug · tier A · 8 trials (3 recruiting) · 7 publications · score 72.5
Pramlintide
Drug · tier A · 8 trials (0 recruiting) · 7 publications · score 55.0
Sitagliptin
Drug · tier A · 8 trials (0 recruiting) · 2 publications · score 52.5
Sirolimus
Drug · tier A · 8 trials (0 recruiting) · 2 publications · score 49.0
Muromonab-Cd3
Drug · tier A · 8 trials (0 recruiting) · 0 publications · score 45.5
Tacrolimus Anhydrous
Drug · tier A · 8 trials (0 recruiting) · 0 publications · score 43.5
Pramlintide Acetate
Drug · tier A · 8 trials (0 recruiting) · 0 publications · score 39.0
Acetazolamide
Drug · tier A · 2 trials (1 recruiting) · 1 publications · score 28.5
Nicotine
Drug · tier A · 1 trials (1 recruiting) · 0 publications · score 23.0
Research map, not treatment advice. Built 2026-10-07.